Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSC for Heart Failure
NCT04939077Phase 2Unknown
- Sponsor
- Shanghai East Hospital
- Start
- Nov 2019
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in heart failure (HF) and Myocardial ischemia (MI), sponsored by Shanghai East Hospital. Primary endpoint: Left ventricular ejection fraction at 720 days. Status: unknown.
02
Conditions
heart failure (HF)Myocardial ischemia (MI)
Beyond the preview
Go deeper on NCT04939077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04939077.